Financial Analysis: IMRIS (IMRSQ) versus CHF Solutions (CHFS)

IMRIS (OTCMKTS:IMRSQ) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations.

Earnings & Valuation

This table compares IMRIS and CHF Solutions’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
CHF Solutions $3.55 million 2.35 -$13.38 million ($37.15) -0.03

IMRIS has higher earnings, but lower revenue than CHF Solutions.


This table compares IMRIS and CHF Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
CHF Solutions -471.94% -166.88% -139.42%

Risk and Volatility

IMRIS has a beta of -3.32, indicating that its stock price is 432% less volatile than the S&P 500. Comparatively, CHF Solutions has a beta of 2.33, indicating that its stock price is 133% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings for IMRIS and CHF Solutions, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IMRIS 0 0 0 0 N/A
CHF Solutions 0 0 1 0 3.00

CHF Solutions has a consensus price target of $3.30, indicating a potential upside of 179.66%. Given CHF Solutions’ higher probable upside, analysts clearly believe CHF Solutions is more favorable than IMRIS.

Insider & Institutional Ownership

20.6% of CHF Solutions shares are held by institutional investors. 3.5% of CHF Solutions shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


CHF Solutions beats IMRIS on 6 of the 9 factors compared between the two stocks.


IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.

About CHF Solutions

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. The company focuses on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. It offers Aquadex FlexFlow consoles and the related disposable products in Singapore and Hong Kong. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.

Receive News & Ratings for IMRIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMRIS and related companies with's FREE daily email newsletter.

Leave a Reply